Stereochemistry of gabapentin and several derivatives: Solid state conformations and solution equilibria

Current Science

Volumn 85, Issue 7, 2003, Pages 1002-1011

  Ananda, K ^a   Aravinda, S ^a   Vasudev, Prema G ^a   Muruga Poopathi Raja, K ^a   Sivaramakrishnan, H ^b   Nagarajan, K ^b   Shamala, N ^a   Balaram, P ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b Hikal Ltd   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1942491356     PISSN: 00113891     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. B receptor pharmacology. Annu. Rev. Pharmacol. Toxicol., 1993, 33, 109-147.
2. Chadwick, D. W. et al., A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International gabapentin monotherapy study group 945-77. Neurology, 1998, 51, 1282-1288.
3. Rosenberg, J. M., Harrell, C., Ristic, H., Werner, R. A. and de Rosayro, A. M., The effect of gabapentin on neuropathic pain. Clin. J. Pain, 1997, 13, 251-255.
4. Maneuf, Y. P., Gonzalez, M, I., Sutton, K. S., Chung, F-Z., Pinnock, R. D. and Lee, K., Cellular and molecular action of the putative GABA-mimetic, gabapentin. Cell. Mol. Life Sci., 2003, 60, 742-750.
5. Ng, G. Y. K. et al., γ-Aminobutyric acid type-B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action. Mol. Pharmacol., 2001, 59, 144-152.
6. B receptor agonist. Neuropharmacology, 2001, 41, 965-975.
7. Jensen, A. A. et al., The anticonvulsant gabapentin (Neurontin) does not act through γ-aminobutyric acid-B receptors. Mol. Pharmacol., 2002, 61, 1377-1384.
8. 2δ subunit of a calcium channel. J. Biol. Chem., 1996, 271, 5768-5776.
9. 2+ influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology, 2002, 42, 229-236.
10. 2+ channels by gabapentin. FEBS Lett., 2002, 528, 177-182.
11. Hutson, S. M., Berkich, D., Drown, P., Xu, B., Aschner, M. and LaNoue, K. F., Role of branched-chain aminotransferase isoenzymes and gabapentin in neurotransmitter metabolism. J. Neurochem., 1998, 71, 863-874.
12. Chuang, D. T. and Shih, V. E., Disorders of branched chain amino acid and keto acid metabolism. In The Metabolic Basis of Inherited Disease (eds Schriver, C. R. et al.), McGraw-Hill, New York, 1995, pp. 1239-1277.
13. Ogston, A. G., Interpretation of experiments on metabolic processes using isotopic tracer elements. Nature, 1948, 162, 963.
14. Bryans, J. S., Horwell, D. C., Ratcliffe, G. S., Receveur, J-M. and Rubin, J. R., An in vitro investigation into conformational aspects of gabapentin. Bioorg. Med. Chem., 1999, 7, 715-721.
15. 2δ subunit of a calcium channel and their evaluation as anticonvulsant agents. J. Med. Chem., 1998, 41, 1838-1845.
16. Ibers, J. A., Gabapentin and gabapentin monohydrate. Acta Crystallogr., Sec. C, 2001, 57, 641-643.
17. Hanessian, S., Luo, X., Schaum, R. and Michnick, S., Design of secondary structures in unnatural peptides: stable helical γ-tetra-, hexa- and octa-peptides and consequences of α-substitution. J. Am. Chem. Soc., 1998, 120, 8569-8570.
18. 2-OH. Helv. Chim. Acta, 1998, 81, 983-1002.
19. 2,3,4-amino acids, coupling to γ-hexapeptides: CD spectra, NMR solution and X-ray crystal structures of γ-peptides. Chem. Eur. J., 2002, 8, 573-584.
20. Aravinda, S., Ananda, K., Shamala, N. and Balaram, P., α-γ Hybrid peptides that contain the conformationally constrained gabapentin residue: Characterization of mimetics of chain reversals. Chem. Eur. J., 2003 (in press).
21. Bodanszky, M. and Bodanszky, A., The Practice of Peptide Synthesis, Springer-Verlag, Berlin, 1984, p. 9; 20.
22. Sheldrick, G. M., SHELXS-97, A program for automatic solution of crystal structures, University of Göttingen, Göttingen, 1997.
23. Sheldrick, G. M., SHELXL-97, A program for crystal structure refinement, University of Göttingen, Göttingen, 1997.
24. Buys, H. R. and Geise, H. J., Conformation of non-aromatic ring compounds, Part 70(1). Electron diffraction investigation on gaseous cyclohexane. Tetrahedron Lett., 1970, 2991-2992.
25. Altona, C. and Sundaralingam, M., Geometry of the substituted cyclohexane ring. X-ray structure determinations and empirical valence-force calculations. Tetrahedron, 1970, 26, 925-939.
26. Chen, L. R., Babu, S. R., Calvitt, C. J. and Tobias, B., New anhydrous crystalline forms of gabapentin. PCT Int. Appl. WO 0331391, 2003.
27. Dunitz, J. D. and Bernstein, J., Disappearing polymorphs. Acc. Chem. Res., 1995, 28, 193-200.
28. Jehle, T., Feuerstein, T. J. and Lagreze, W. A., The effect of gabapentin and gabapentin-lactam on retinal ganglion cell survival in an animal model in acute retina ischemia. Ophthalmologe, 2001, 98, 237-241.
29. Venkatesan, K. and Ramakumar, S., X-ray crystallographic studies on the conformational features and the packing modes of amides. In Structural Studies on Molecules of Biological Interest (eds Dodson, G., Glusker, J. P. and Sayre, D.), 1981, pp. 137-153.
30. Banerjee, A. and Balaram, P., Stereochemistry of peptides and polypeptides containing omega amino acids. Curr. Sci., 1997, 73, 1067-1077.